Drug intelligence / Profile preview

Femiflor

Development stage: Unknown
Lead developer: Laboratoires Élerté
Modality: Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
Administration: Oral

Overview

Femiflor is an oral dietary supplement developed by Laboratoires Élerté, specifically formulated to support gynecological health by maintaining the balance of the vaginal microbiota. It contains a combination of two probiotic strains, *Lactobacillus rhamnosus* Rosell-11 and *Lactobacillus helveticus* Rosell-52, along with Vitamin B2 (riboflavin). These probiotics work by colonizing the intestinal tract and subsequently the vaginal environment, where they produce lactic acid to maintain an acidic pH and competitively inhibit the growth of pathogens such as *Candida albicans* and bacteria associated with bacterial vaginosis. Vitamin B2 is included to support the maintenance of healthy mucous membranes. Femiflor is primarily used as a complementary approach to prevent or manage vaginal dysbiosis and recurrent gynecological infections.

Brand names: Femiflor

Beyond the preview

Go deeper on Femiflor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Femiflor.

Explore the full profile